Last updated 51 days ago
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
792 patients around the world
Available in Brazil, Argentina, Mexico, Chile
Gilead Sciences
22Research sites
792Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro Médico Privado CEMAIC - Córdoba
Recruiting
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Hospital Provincial del Centenario - Rosario, Santa Fe
Recruiting
Swiss Medical Center Barrio Parque - CABA
Recruiting
Sanatorio Allende (Nueva Córdoba)
Recruiting
Sanatorio Británico - Rosario
Recruiting
Sanatorio Parque - Rosario
Recruiting
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Recruiting
Centro Médico Caipo (centro para la atención integral de pacientes oncológicos)
Recruiting
StudySTAR-121
SponsorGilead Sciences
Study typeInterventional
Conditions
Non-small cell lung carcinomaLung cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05502237
